The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The endogenous cannabinoid system controls extinction of aversive memories
Abstract
Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom. In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction, its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1) and endocannabinoids are present in memory-related brain areas and modulate memory. Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex, a region known to control extinction of aversive memories. In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following their binding to central nervous system receptors (e.g.CB1 receptors), endocannabinoids have been shown, e.g., to reduce anxiety (Marsicano et al., 2002;Lutz et al., 2015) and increase food intake (Di Marzo et al., 2001).”
From Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (2016) · cites this paper as Marsicano et al., 2002
In the citing paper
“Moreover, there is an emerging body of evidence demonstrating an important role for CB1 receptor-mediated endocannabinoid signaling in the extinction of aversive memories8.”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [8]
In the citing paper
“As part of this protective role under aversive conditions, elevated EC signaling during stress has been shown to dampen the development of anxiety [12] and to regulate the encoding [13], retrieval [14] and extinction [15] of traumatic memories.”
From Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder (2013) · cites this paper as [15]
In the citing paper
“Additionally, inhibition of FAAH facilitates long-term fear extinction and rescues deficient fear extinction in rodent models by enhancing AEA–CB1 (cannabinoid type 1) receptor signaling and synaptic plasticity in the BLA.”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“Marsicano and colleagues reported elevated AEA and 2-AG BLA levels after extinction training in mice [86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“One notable finding is that a CB1R-dependent form of synaptic plasticity in BLA [51,86], long-term depression of inhibitory GABAergic transmission (LTDi), is enhanced by FAAH KO [51] and by the FAAH inhibitor AM3506 at doses that promote extinction [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“and produced impairments in extinction learning (but not fear conditioning) by CB1R KO or systemic antagonist (SR141716A) administration [28,86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“This suggests a scheme in which AEA released during extinction relieves a tonic inhibitory brake on BLA output neurons [50,51,86] necessary for the encoding of extinction memories [102] (Figure 2).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“The cannabinoid system is part of the complex circuitry that regulates anxiety and stress and is a crucial mediator of emotional learning (Marsicano et al, 2002;Viveros et al, 2005;Patel et al, 2005Patel et al, , 2005a; Laviolette and Grace, 2006;Varvel et al, 2007;Ganon-Elazar and Akirav, 2009;Lutz, 2009;Hill et al, 2009;Abush and Akirav, 2010;Akirav, 2011).”
From Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (2012) · cites this paper as Marsicano et al, 2002
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Genetic enhancement of learning and memory in mice
Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,878
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
The role of ventromedial prefrontal cortex in the recovery of extinguished fear
Quirk, G. J., Russo, G. K., Barron, J. L., & Lebron, K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06225.2000 · Cited by 957 · cited 1×
“; however, there is increasing evidence that some cellular pathways are specifically involved in extinction, but not in acquisition or consolidation of fear memorie”
BackgroundMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Self-citationExtinction of emotional learning: contribution of medial prefrontal cortex
Morgan, M. A., Romanski, L. M., & LeDoux, J. E. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90241-c · Cited by 897 · cited 1×
“To confirm this assumption, we measured in C57BL/6J mice levels of the two major endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), in brain punches of the medial prefrontal cortex (mPFC) and the basolateral amygdala complex (BLAC), both of which are thought to have central roles in extinction of av…”
BackgroundOhno‐Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 874
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Flagged first, then by citations
Research works printed but not linked: 1
- Franklin, K. B. J. & Paxinos, G. The Mouse Brain (Academic, San Diego, 1997)
Cited by
Sorted by citations
Items 201–300 of 1,005
Endocannabinoids in Amygdala and Nucleus Accumbens Mediate Social Play Reward in Adolescent Rats
Trezza, V., Damsteegt, R., Manduca, A., Petrosino, S., Van Kerkhof, L. W. M., Pasterkamp, R. J., Zhou, Y., Campolongo, P., Cuomo, V., Di Marzo, V., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0114-12.2012 · Cited by 190
Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia
Mátyás, F., Yanovsky, Y., Mackie, K., Kelsch, W., Misgeld, U., & Freund, T. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.005 · Cited by 197
Cannabidiol enhances consolidation of explicit fear extinction in humans
Das, R., Kamboj, S. K., Ramadas, M., Yogan, K., Gupta, V., Redman, E., Curran, H. V., & Morgan, C. J. A. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2955-y · Cited by 200
Russo, E. B. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0009 · Cited by 193
Laviolette, S. R., & Grace, A. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0707-06.2006 · Cited by 189
Spinal Endocannabinoids and CB 1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization
Pernía‐Andrade, A. J., Kato, A., Witschi, R., Nyilas, R., Katona, I., Freund, T. F., Watanabe, M., Filitz, J., Koppert, W., Schüttler, J., et al. (2009) · Science · doi:10.1126/science.1171870 · Cited by 184
Self-citationHashimotodani, Y., Ohno‐Shosaku, T., & Kano, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4159-06.2007 · Cited by 186
Cannabinoids modulate hippocampal memory and plasticity
Abush, H., & Akirav, I. (2010) · Hippocampus · doi:10.1002/hipo.20711 · Cited by 186
Хаспеков, Л. Г., Verca, M. S. B., Frumkina, L. E., Hermann, H., Marsicano, G., & Lutz, B. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03285.x · Cited by 184
Self-citationHindocha, C., Freeman, T. P., Schäfer, G., Gardener, C., Das, R., Morgan, C. J. A., & Curran, H. V. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.014 · Cited by 192
Fear Extinction Causes Target-Specific Remodeling of Perisomatic Inhibitory Synapses
Trouche, S. G., Sasaki, J. M., Tu, T., & Reijmers, L. G. J. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.047 · Cited by 192
Cellular and molecular connections between sleep and synaptic plasticity
Benington, J. H., & Frank, M. G. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00018-2 · Cited by 244
Smoking tobacco along with marijuana increases symptoms of cannabis dependence
Ream, G. L., Benoit, E., Johnson, B. D., & Dunlap, E. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.01.011 · Cited by 181
Kida, S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5086-2 · Cited by 188
Houchi, H., Babovic, D., Pierrefiche, O., Ledent, C. A., Daoust, M., & Naassïla, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300568 · Cited by 181
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188
Flor, H. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.809 · Cited by 184
Forniceal deep brain stimulation rescues hippocampal memory in Rett syndrome mice
Hao, S., Tang, B., Wu, Z., Ure, K., Sun, Y., Tao, H., Gao, Y., Patel, A. J., Curry, D. J., Samaco, R. C., et al. (2015) · Nature · doi:10.1038/nature15694 · Cited by 185
Self-citationCannabinoid Mechanisms of Pain Suppression
Walker, J. M., & Hohmann, A. G. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 177
Moreira, F. A., & Wotjak, C. T. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_16 · Cited by 177
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S., & Mackie, K. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 187
Maione, S., Piscitelli, F., Gatta, L., Vita, D. D., PETROCELLIS, L. D., Palazzo, E., de Novellis, V., & Marzo, V. D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01063.x · Cited by 186
Grotenhermen, F. (2004) · PubMed · Cited by 175
Pharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy
Davis, M., Myers, K. M., Chhatwal, J., & Ressler, K. J. (2006) · NeuroRX · doi:10.1016/j.nurx.2005.12.008 · Cited by 174
Ganon-Elazar, E., & Akirav, I. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1223-09.2009 · Cited by 173
Varvel, S. A., Wise, L. E., Niyuhire, F., Cravatt, B. F., & Lichtman, A. H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301224 · Cited by 179
Cannabinoids and prefrontal cortical function: Insights from preclinical studies
Egerton, A., Allison, C., Brett, R. R., & Pratt, J. A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.12.002 · Cited by 177
Hill, M. N., Hillard, C. J., Bambico, F. R., Patel, S., Gorzalka, B. B., & Gobbi, G. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.006 · Cited by 175
Presynaptic LTP and LTD of Excitatory and Inhibitory SynapsesPreprint
Castillo, P. E. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005728 · Cited by 186
Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice
Häring, M., Marsicano, G., Lutz, B., & Monory, K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.021 · Cited by 181
Self-citationLaviolette, S. R., & Grace, A. A. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6027-5 · Cited by 172
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
Marzo, V. D., & PETROCELLIS, L. D. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.011205.135648 · Cited by 173
Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis
Steiner, M. S., & Wotjak, C. T. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00433-0 · Cited by 174
Self-citationStorr, M., Keenan, C. M., Emmerdinger, D., Zhang, H., Yüce, B., Sibaev, A., Massa, F., Buckley, N. E., Lutz, B., Göke, B., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0359-6 · Cited by 170
Self-citationRecent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics
Mathew, S. J., Price, R. B., & Charney, D. S. (2008) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30172 · Cited by 172
Anxiety, stress, and fear response in mice with reduced endocannabinoid levels
Jenniches, I., Ternes, S., Albayram, O., Otte, D. M., Bach, K., Bindila, L., Michel, K., Lutz, B., Bilkei-Gorzo, A., & Zimmer, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.033 · Cited by 169
Self-citationAguado, T., Romero, E., Monory, K., Palazuelos, J., Sendtner, M., Marsicano, G., Lutz, B., Guzmán, M., & Galve‐Roperh, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700678200 · Cited by 170
Self-citationMayo, L. M., Asratian, A., Lindé, J., Holm, L., Nätt, D., Augier, G., Stensson, N., Vecchiarelli, H. A., Balsevich, G., Aukema, R. J., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0215-1 · Cited by 175
Neurobiology of anxiety disorders and implications for treatment.
Garakani, A., Mathew, S. J., & Charney, D. S. (2006) · PubMed · Cited by 166
Ohno‐Shosaku, T., Matsui, M., Fukudome, Y., Shosaku, J., Tsubokawa, H., Taketo, M. M., Manabe, T., & Kano, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02732.x · Cited by 166
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors
Bilkei‐Gorzó, A., Rácz, I., Valverde, O., Otto, M., Michel, K., Sarstre, M., & Zimmer, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504640102 · Cited by 166
Patel, S., Cravatt, B. F., & Hillard, C. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300535 · Cited by 164
Izzo, A. A., Piscitelli, F., Capasso, R., Aviello, G., Romano, B., Borrelli, F., Petrosino, S., & Marzo, V. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00183.x · Cited by 164
Identification of Calcineurin as a Key Signal in the Extinction of Fear Memory
Lin, C.-H., Yeh, S.-H., Leu, T., Chang, W., Wang, S., & Gean, P. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01574.2003 · Cited by 164
Patel, S., & Hillard, C. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06266.x · Cited by 162
Cannabinoid receptors: nomenclature and pharmacological principles
Console‐Bram, L., Marcu, J. P., & Abood, M. E. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.009 · Cited by 169
Fatty acid amide signaling molecules
Ezzili, C., Otrubova, K., & Boger, D. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.048 · Cited by 172
The role of the amygdala in the extinction of conditioned fear.
Barad, M., Gean, P., & Lutz, B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.029 · Cited by 168
Self-citationde Azúa, I. R., Mancini, G., Srivastava, R. K., Rey, A. A., Cardinal, P., Tedesco, L., Zingaretti, C. M., Sassmann, A., Quarta, C., Schwitter, C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci83626 · Cited by 168
Self-citationAntioxidant Therapy in Alzheimers Disease: Theory and Practice
Aliev, G., Obrenovich, M. E., Reddy, V. P., Shenk, J. C., Moreira, P. I., Nunomura, A., Zhu, X., Smith, M. A., & Perry, G. L. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369582 · Cited by 160
Associative Short-Term Synaptic Plasticity Mediated by Endocannabinoids
Brenowitz, S. D., & Regehr, W. G. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.045 · Cited by 159
Reduced sensitivity to reward in CB1 knockout mice
Sanchis‐Segura, C., Cline, B. H., Marsicano, G., Lutz, B., & Spanagel, R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1877-8 · Cited by 158
Self-citationParker, L. A., Burton, P., Sorge, R. E., Yakiwchuk, C., & Mechoulam, R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1825-7 · Cited by 171
Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series
Elms, L., Shannon, S. M., Hughes, S., & Lewis, N. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0437 · Cited by 156
Patel, S., Kingsley, P. J., Mackie, K., Marnett, L. J., & Winder, D. G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.101 · Cited by 153
“These data seem discordant, however, earlier studies have shown that in vivo exposure to CB1 agonists can decrease CB1 receptor sensitivity without affecting receptor number or signaling efficacy (Mato et al, 2004).”
Bowers, M. E., Choi, D. C., & Ressler, K. J. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.004 · Cited by 155
Marinelli, S., Marzo, V. D., Florenzano, F., Fezza, F., Viscomi, M. T., van der Stelt, M., Bernardi, G., Molinari, M., Maccarrone, M., & Mercuri, N. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301118 · Cited by 155
Petrosino, S., Verde, R., Vaia, M., Allarà, M., Iuvone, T., & Marzo, V. D. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244368 · Cited by 164
A role for cannabinoid CB1 receptors in mood and anxiety disorders
Witkin, J. M., Tzavara, E. T., & Nomikos, G. G. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00005 · Cited by 160
Can fear extinction be enhanced? A review of pharmacological and behavioral findings
Fitzgerald, P. J., Seemann, J. R., & Maren, S. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.007 · Cited by 167
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Fernández‐Espejo, E., Viveros, M., Núñez, L., Ellenbroek, B. A., & de Fonseca, F. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1612-6 · Cited by 155
Watanabe, S., Doshi, M., & Hamazaki, T. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00056-5 · Cited by 168
Wang, X., Sarris, K., Kage, K., Zhang, D., Brown, S. P., Kolasa, T., Surowy, C. S., El-Kouhen, O. F., Muchmore, S. W., Brioni, J. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801042a · Cited by 154
CB1 receptor-deficient mice as a model for depression
Valverde, O., & Torrens, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.031 · Cited by 156
Hebert-Chatelain, E., Reguero, L., Puente, N., Lutz, B., Chaouloff, F., Rossignol, R., Piazza, P.-V., Benard, G., Grandes, P., & Marsicano, G. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.03.007 · Cited by 151
Self-citationThe endocannabinoid system and psychiatric disorders
Parolaro, D., Realini, N., Viganò, D., Guidali, C., & Rubino, T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.018 · Cited by 151
Tzavara, E. T., Wade, M. R., & Nomikos, G. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09374.2003 · Cited by 151
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids
Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_5 · Cited by 152
Self-citationDissociation of within- and between-Session Extinction of Conditioned Fear
Plendl, W., & Wotjak, C. T. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6038-09.2010 · Cited by 162
Self-citationPresynaptic Spike Timing-Dependent Long-Term Depression in the Mouse Hippocampus
Andrade‐Talavera, Y., Duque‐Feria, P., Paulsen, O., & Moreno, A. R. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw172 · Cited by 152
Dubreucq, S., Matias, I., Cardinal, P., Häring, M., Lutz, B., Marsicano, G., & Chaouloff, F. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.36 · Cited by 158
Self-citationPan, B., Wang, W., Zhong, P., Blankman, J. L., Cravatt, B. F., & Liu, Q.-S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2075-11.2011 · Cited by 160
PTSD: from neurobiology to pharmacological treatments
Kelmendi, B., Adams, T., Yarnell, S. C., Southwick, S., Abdallah, C., & Krystal, J. (2016) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v7.31858 · Cited by 136
Bowers, M. E., & Ressler, K. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.008 · Cited by 155
Rabinak, C. A., Angstadt, M., Lyons, M., Mori, S., Milad, M. R., Liberzon, I., & Phan, K. L. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.09.009 · Cited by 148
Endocannabinoids in Chronic Migraine: CSF Findings Suggest a System Failure
Sarchielli, P., Pini, L. A., Coppola, F., Rossi, C., Baldi, A., Mancini, M. L., & Calabresi, P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301246 · Cited by 146
Morena, M., Roozendaal, B., Trezza, V., Ratano, P., Peloso, A., Hauer, D., Atsak, P., Trabace, L., Cuomo, V., McGaugh, J. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420285111 · Cited by 150
Sex-dependent effects of in utero cannabinoid exposure on cortical function
Bara, A., Manduca, A., Bernabeu, A., Borsoï, M., Serviado, M., Lassalle, O., Murphy, M. N., Wager‐Miller, J., Mackie, K., Pélissier‐Alicot, A., et al. (2018) · eLife · doi:10.7554/elife.36234 · Cited by 150
Tedesco, L., Valerio, A., Cervino, C., Cardile, A., Pagano, C., Vettor, R., Pasquali, R., Carruba, M. O., Marsicano, G., Lutz, B., et al. (2008) · Diabetes · doi:10.2337/db07-1623 · Cited by 145
Self-citationRepeated Stress Impairs Endocannabinoid Signaling in the Paraventricular Nucleus of the Hypothalamus
Cusulin, J. I. W., Kuzmiski, J. B., & Bains, J. S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1046-10.2010 · Cited by 153
Endocannabinoid system dysfunction in mood and related disorders
Ashton, C. H., & Moore, P. B. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01687.x · Cited by 150
The endocannabinoid system: An emotional buffer in the modulation of memory function
Morena, M., & Campolongo, P. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.12.010 · Cited by 153
Wesley, M. J., Hanlon, C. A., & Porrino, L. J. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.10.002 · Cited by 144
Chiu, C. Q., Puente, N., Grandes, P., & Castillo, P. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0736-10.2010 · Cited by 143
A hippocampal Cdk5 pathway regulates extinction of contextual fear
Sananbenesi, F., Fischer, A., Wang, X., Schrick, C., Neve, R. L., Radulović, J., & Tsai, L. (2007) · Nature Neuroscience · doi:10.1038/nn1943 · Cited by 143
Emerging roles for endocannabinoids in long‐term synaptic plasticity
Gerdeman, G. L., & Lovinger, D. M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705466 · Cited by 144
Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction
de Oliveira Alvares, L., Pasqualini Genro, B., Diehl, F., Molina, V. A., & Quillfeldt, J. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.005 · Cited by 143
Steiner, M. A., Marsicano, G., Nestler, E. J., Holsboer, F., Lutz, B., & Wotjak, C. T. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.09.008 · Cited by 146
Self-citationRiebe, C. J. N., & Wotjak, C. T. (2011) · Stress · doi:10.3109/10253890.2011.586753 · Cited by 149
Self-citationWIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors
Pamplona, F. A., & Takahashi, R. N. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.026 · Cited by 141
Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses
Viveros, M., Marco, E. M., Llorente, R., & López‐Gallardo, M. (2007) · Neural Plasticity · doi:10.1155/2007/52908 · Cited by 151
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
Blázquez, C., Chiarlone, A., Bellocchio, L., Resel, E., Pruunsild, P., García-Rincón, D., Sendtner, M., Timmusk, T., Lutz, B., Galve‐Roperh, I., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.11 · Cited by 143
Self-citationSuzuki, A., Mukawa, T., Tsukagoshi, A., Frankland, P. W., & Kida, S. (2008) · Learning & Memory · doi:10.1101/lm.888808 · Cited by 141
Wu, C., Zhu, J., Wager‐Miller, J., Wang, S., O’Leary, D. D. M., Monory, K., Lutz, B., Mackie, K., & Lu, H. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07337.x · Cited by 143
Self-citationRácz, I., Bilkei‐Gorzó, A., Tóth, Z., Michel, K., Palkovits, M., & Zimmer, A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02453.2003 · Cited by 140
Roles of the Endocannabinoid System in Learning and Memory
Marsicano, G., & Lafenêtre, P. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_8 · Cited by 153
Self-citationCampos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139
Presynaptic long-term plasticity
Yang, Y., & Calakos, N. (2013) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2013.00008 · Cited by 147
Metadata
- Authors
- Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., Di Marzo, V., & Lutz, B.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- LMU Klinikum (DE)
- Istituto di Chimica Biomolecolare (IT)
- Helmholtz Munich (DE)
- Corresponding author
- Lutz, Beat
- Venue
- Nature
- Published
- 2002-08
- Volume
- 418
- Issue
- 6897
- Pages
- 530-534
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982291289
- Cited by
- 1,728
- References
- 30
- Citations by year
- 2026: 22 · 2025: 39 · 2024: 41 · 2023: 48 · 2022: 60 · 2021: 61 · 2020: 60 · 2019: 70 · 2018: 64 · 2017: 77 · 2016: 75 · 2015: 87 · 2014: 90 · 2013: 87 · 2012: 85
- FWCI
- 42.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, CB1 knockout mice, fear extinction, auditory fear conditioning, basolateral amygdala, long-term depression, GABAergic inhibition, SR141716A, memory consolidation, inhibitory neural networks
- MeSH terms
- Rimonabant, Acoustic Stimulation, Amygdala, Animals, Cannabinoids, Conditioning, Classical, Electrophysiology, Extinction, Psychological, Fear, gamma-Aminobutyric Acid, Male, Memory, Mice, Inbred C57BL, Neuronal Plasticity, Neurons, Piperidines, Pyrazoles, Receptors, Drug, Synapses, Gene Deletion, Mice, Knockout, Receptors, Cannabinoid, Mice, Cannabinoid Receptor Modulators, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
